SEC Filings
Filing date | Description | Form | Filing Group | Issuer | View |
---|---|---|---|---|---|
View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
View HTML | Filing of certain prospectuses and communications in connection with business combination transactions |
425 |
Other
|
Eidos Therapeutics, Inc. | |
View HTML | Filing of certain prospectuses and communications in connection with business combination transactions |
425 |
Other
|
Eidos Therapeutics, Inc. | |
View HTML | Filing of certain prospectuses and communications in connection with business combination transactions |
425 |
Other
|
Eidos Therapeutics, Inc. | |
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | Report of unscheduled material events or corporate event |
8-K |
Current Reports
|
Eidos Therapeutics, Inc. | |
View HTML | Filing of certain prospectuses and communications in connection with business combination transactions |
425 |
Other
|
Eidos Therapeutics, Inc. | |
View HTML | Filing of certain prospectuses and communications in connection with business combination transactions |
425 |
Other
|
Eidos Therapeutics, Inc. | |
View HTML | Filing of certain prospectuses and communications in connection with business combination transactions |
425 |
Other
|
Eidos Therapeutics, Inc. | |
View HTML | Filing of certain prospectuses and communications in connection with business combination transactions |
425 |
Other
|
Eidos Therapeutics, Inc. |
Data provided by Kaleidoscope.